← Open Payments lookup

KEBAI BILLS: Open Payments

NPI 1750342952 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$682 in 36 payments from 11 companies in 2025. Trend: 2023 $435 · 2024 $754 · 2025 $682

Food & beverage: $682
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$170
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$111
Axsome Therapeutics, Inc.3$72
ABBVIE INC.3$57
Alkermes, Inc.3$52
E.R. Squibb & Sons, L.L.C.3$51
Vanda Pharmaceuticals Inc.2$44
Otsuka America Pharmaceutical, Inc.2$42
Janssen Pharmaceuticals, Inc2$41
Takeda Pharmaceuticals U.S.A., Inc.1$21

Products named: CAPLYTA, AUSTEDO XR, UZEDY, Auvelity, VRAYLAR, COBENFY, FANAPT, ABILIFY ASIMTUFII.

Industry payments across ID — which companies pay providers there.